Analyst Ratings For DRIO – DarioHealth (NASDAQ:DRIO)
Today, Chardan Capital initiated coverage on DRIO – DarioHealth (NASDAQ:DRIO) with a Buy.
Some recent analyst ratings include
- 4/9/2018-Chardan Capital initiated coverage with a Buy rating.
- 12/8/2017-Aegis Reiterated Rating of Buy.
- 8/22/2016-Rodman & Renshaw Reiterated Rating of Buy.
Recent Insider Trading Activity For DRIO – DarioHealth (NASDAQ:DRIO)
DRIO – DarioHealth (NASDAQ:DRIO) has insider ownership of 30.00% and institutional ownership of 1.67%.
- On 2/28/2018 Zvi Ben-David, CFO, bought 9,018 with an average share price of $1.40 per share and the total transaction amounting to $12,625.20.
- On 8/19/2016 Erez Raphael, CEO, bought 500 with an average share price of $3.57 per share and the total transaction amounting to $1,785.00.
Recent Trading Activity for DRIO – DarioHealth (NASDAQ:DRIO)
Shares of DRIO – DarioHealth closed the previous trading session at 1.63 up +0.05 3.16% with 206627 shares trading hands.